ArticleNeurodegenerative disease management2025

Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS.

Le H Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.